Abstract
Oral once-daily, fixed-dose, ledipasvir/sofosbuvir (Harvoni((R))) [+/- ribavirin] is approved in several countries for the treatment of chronic hepati......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
